KraneShares MSCI All China Health Care Index ETF KURE
18.74 USD -0.16 (-0.85%)
Nov 10, 2026, 3:59 PM EST
18.54 Day range 18.86
14.38 52-week range 19.93
- YTD
- +9.98%
- 1 year
- -1.78%
News
benzinga.com Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
benzinga.com Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."
etftrends.com Should EM Investors Trim or Retain Their China Exposure? Getting emerging market exposure is a viable option in the current market environment. That's especially so given the global de-dollarization and prospect of further rate cuts by the Federal Reserve.
benzinga.com Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
etftrends.com Capitalize on China Healthcare Fundraising With KURE Looking for a reason to consider adding exposure to the China healthcare sector to your portfolio? Now may actually be a very good time to do so.
benzinga.com Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
benzinga.com Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.
benzinga.com Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' Barclays has said that it's hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.
benzinga.com Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
benzinga.com Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
benzinga.com Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
etftrends.com China's Healthcare ETFs Outpace U.S. Competitors When it comes to creating a well-diversified portfolio, healthcare stocks have traditionally offered a variety of benefits. As an innovative sector, healthcare companies offer the potential to build…
marketbeat.com 3 ETFs Thriving in April's Market Chaos—Are You Missing Out? With markets see-sawing up and down on a daily (or even minute-by-minute) basis on hints of global tariffs updates, there's an opportunity to time an investment to win short-term gains.
benzinga.com Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.
benzinga.com China's Market Rebound: Is The NPC Meeting A Turning Point For Investors? China's NPC meeting has sparked optimism in the market, with Chinese stocks and bonds rallying. Investors are hopeful for growth targets but remain skeptical.
etftrends.com A KURE for China Tariff Concerns An escalating trade war with China elevates a number of risk factors, but also creates pockets of overlooked opportunity for those with the appetite. Advisors and investors looking for contrarian…
seekingalpha.com China's Stalling Credit Market Signals an Era Of Stagnation The latest figures published by the People's Bank of China show that credit and liquidity are stalling as demand for new loans declines. Deteriorating confidence in China's prospects explains why…
seekingalpha.com China's Key Growth Indicators Continue To Present A Case For Further Policy Easing Data came in generally in line or slightly weaker than forecasts, as weak confidence continued to depress investment and consumption. New home prices fell by -0.65% MoM in July, compared to a -0.67%…
seekingalpha.com China's Sluggish May Economic Data To Increase Calls For Rate Cuts The People's Bank of China kept the one-year medium-term lending facility rate unchanged at 2.5% today, in line with market expectations. We believe that in conjunction with today's data releases and…
seekingalpha.com China Accelerates Policy Support Rollout Amid Mixed Data Key economic indicators are mixed in China and, in fact, were mostly weaker than expected last month. So, policymakers are now stepping up support for the property sector in particular.
seekingalpha.com China's Economy Is Not In A Great Decline But A Great Transition China's near-term challenges and long-term uncertainties are plentiful, but the widespread pessimism towards the Chinese economy and markets feels excessive.
seekingalpha.com PBOC Held Rates Steady In March The PBOC held the 1-year medium-term lending facility (MLF) rate at 2.5% in March. The PBOC remains on a dovish tilt, but depreciation pressure on the RMB limits room for monetary easing in China…
etftrends.com 3 Thematic China ETFs for An Uncertain Outlook China investing remains an important consideration for investors, despite some economic uncertainty. The country's government has yet to unleash its most powerful tools to boost the economy.
seekingalpha.com Enter The Dragon: Parsing Lunar New Year Opportunities Among Emerging Markets China and Hong Kong markets had a humbling 2023 with equities down more than 10%. Beijing has also begun stepping up tourism and travel promotions, granting visa-free entry to 11 countries, with…
seekingalpha.com Why China May Need To Do More To Boost Investor Confidence Why China May Need To Do More To Boost Investor Confidence
seekingalpha.com China Begins Year Of The Dragon With Weak Economic Momentum The Chinese economy is stabilising, but the only fireworks will come from the new year celebrations, which begin on February 11, as momentum remains weak. China's GDP growth for the fourth quarter…
seekingalpha.com China Growth Could Slow Amid Limited Policy Options While recent policy announcements and data surprises have generated some optimism, we maintain a cautious stance on China's economic prospects. We believe weak consumption trends, a downbeat labor…
seekingalpha.com China Outlook: Market Rescue Welcomed, But More Needed In response to the recent China equity market rout, policymakers vowed last week to stabilize the market through more forceful measures. Despite a very positive initial market reaction (an 8% rebound…
seekingalpha.com Restarting China's Economic Growth China's government is finally moving to stimulate the economy after its sluggish post-COVID reopening.
seekingalpha.com China Canary Warns About Global Economy And The Downside To Euphoria Chinese stock prices have lost money in the 16 years since 2007 and are now back near 2005 levels. Chinese treasury bonds have rallied sharply as beaten-up capital capitulates out of riskier markets…
zacks.com ETFs to Tap China's Economic Resurgence in 2024 With promising economic data and optimistic growth projections, the Chinese economy stands poised for a potential resurgence in 2024. Explore ETFs to leverage and capitalize on China's anticipated…
benzinga.com KraneShares Joins Forces With Dorsey Wright For ETF Rotation Model